Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
about
Collagen-derived matricryptins promote inhibitory nerve terminal formation in the developing neocortex.The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.Loss of Interneuron-Derived Collagen XIX Leads to a Reduction in Perineuronal Nets in the Mammalian Telencephalon.
P2860
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@ast
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@en
type
label
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@ast
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@en
prefLabel
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@ast
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.
@en
P2093
P2860
P356
P1433
P1476
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX
@en
P2093
Alexia Vautrin
Aurelie Dupont-Deshorgue
Bertrand Brassart
Carine Machado
Christèle Sellier
Dominique Harakat
François-Xavier Maquart
Jean-Baptiste Oudart
Jean-Claude Monboisse
Laurent Ramont
P2860
P304
P356
10.18632/ONCOTARGET.2849
P407
P577
2015-02-01T00:00:00Z